•  
  •  
 

Lama Rawat Inap Pasien Terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia dan Faktor Yang Mempengaruhinya.

Abstract

Banyaknya kasus COVID-19 membuat daya tampung fasilitas kesehatan hampir tidak mencukupi untuk memberikan pelayanan medis rawat inap yang memadai pada pasien COVID- 19. Studi yang dilakukan di beberapa negara seperti China, Beijing, Vietnam, Amerika Serikat melaporkan durasi dan faktor risiko rawat inap pasien COVID-19 yang bervariasi. Namun, saat ini penelitian tentang durasi dan faktor risiko lama rawat inap pasien COVID-19 di Indonesia masih terbatas. Penelitian bertujuan mengetahui faktor risiko lama rawat inap pasien terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia (RSUI). Desain studi potong lintang dilakukan pada 266 pasien terkonfirmasi COVID-19 yang dirawat inap di RSUI selama Maret sampai dengan September 2020. Studi ini menilai faktor resiko usia, jenis kelamin, area tinggal, gambaran radiologi, pekerjaan, gejala, keparahan penyakit, komorbiditas, jumlah obat pada hari pertama rawat, dan status PCR saat akhir rawat. Data berasal dari rekam medis elektronik RSUI. Analisa data melalui uji chi square, Kruskal-Walis dilakukan untuk melihat perbedaan variabel kategorik dan numerik. Analisa multivariat regresi logistik dilakukan untuk menentukan prediktor lama rawat inap pasien terkonfirmasi COVID-19 di RSUI. Hasil penelitian didapatkan bahwa median lama rawat inap adalah 13 hari (range 3 – 74 hari). Adapun prediktor rawat inap lebih panjang (>14 hari) adalah pada pria (OR 1,80, 95%CI 1,03 – 3,15), dan pasien dengan gambaran pneumonia (OR 1,68, 95%CI 0,95 – 3,00), diabetes mellitus (OR 3,48, 95%CI 1,11 – 10,92), demam (OR 2,30, 95%CI 1,31 – 4,05), anosmia (OR 4,10, 95%CI 1,60 – 10,48), keparahan sedang (OR 1,64, 95%CI 0,88 – 3,06), keparahan berat (OR 13,31, 95%CI 1,64 – 107,72). Disimpulkan bahwa tingkat keparahan berat, anosmia, diabetes mellitus, demam, pasien pria dan gambaran pneumonia merupakan faktor risiko signifikan yang berhubungan dengan lama rawat inap pasien terkonfirmasi COVID-19 di RSUI Depok. Pasien dengan faktor risiko tersebut diatas untuk lebih diprioritaskan dalam penanganan medis karena rentan terhadap lama rawat inap yang panjang

References

  1. World Health Organization. Coronavirus Update. https://www.who.int/health-topics/coronavirus#tab=tab_1.
  2. Coronavirus Update (Live): 128,808,498 Cases and2,816,038 Deaths from COVID-19 Virus Pandemic -Worldometer. https://www.worldometers.info/coronavirus/?%23countries#countries. Accessed March 31, 2021.
  3. Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed March 31, 2021.
  4. Kota Depok I Covid-19. https://ccc-19.depok.go.id/.Accessed March 31, 2021.
  5. Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length ofhospital stay: a systematic review and data synthesis.medRxiv. 2020:2020.04.30.20084780.
  6. Zhao W, Yu S, Zha X, et al. Clinical characteristics anddurations of hospitalized patients with COVID-19 in Beijing:a retrospective cohort study. 2020;(April).
  7. Surendra H, Elyazar IRF, Djaafara BA, et al. Clinicalcharacteristics and mortality associated with COVID-19 inJakarta, Indonesia: a hospital-based retrospective cohortstudy. medRxiv. 2020.
  8. wang zhuo, Ji JS, Liu Y, et al. Survival analysis of hospitallength of stay of novel coronavirus (COVID-19) pneumoniapatients in Sichuan, China. medRxiv.2020:2020.04.07.20057299.
  9. Ko JY, Danielson ML, Town M, et al. Risk Factors for COVID-19-associated hospitalization: COVID-19-AssociatedHospitalization Surveillance Network and Behavioral RiskFactor Surveillance System. medRxiv. January2020:2020.07.27.20161810.
  10. Thai PQ, Son DT, Van HTH, et al. Factors associated withthe duration of hospitalisation among COVID-19 patients inVietnam: A survival analysis. Epidemiol Infect. 2020;148.
  11. Liu X, Zhou H, Zhou Y, et al. Risk factors associated withdisease severity and length of hospital stay in COVID-19patients. J Infect. 2020;81(1):e95-e97.
  12. Channel RSUI. Tema/ : Pengalaman RSUI Sebagai RSRujukan COVID-19. Indonesia; 2020. https://www.youtube.com/watch?v=K8hEQb1yTmU.
  13. Keputusan Menteri Kesehatan Republik Indonesia.HK.01.07/MENKES/247/2020 Tentang Pedoman pencegahandan pengendalian. 2020;2019:1-127.
  14. Keputusan Menteri Kesehatan Republik Indonesia.Keputusan Menteri Kesehatan Republik Indonesia NomorHK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahandan Pengendalian Corona Virus Disease 2019 (Covid-19).MenKes/413/2020. 2020;2019:207.
  15. Siordia JA. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol.2020;127(April):104357. doi:10.1016/j.jcv.2020.104357
  16. McQueenie R, Foster H, Jani BD, et al. Multimorbidity,Polypharmacy, and COVID-19 infection within the UKBiobank cohort. medRxiv. 2020:2020.06.10.20127563.
  17. Wu Y, Hou B, Liu J, Chen Y, Zhong P. Risk Factors AssociatedWith Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front Med.2020;7:315.
  18. Wu S, Xue L, Legido-Quigley H, et al. Understanding factorsinfluencing the length of hospital stay among non-severeCOVID-19 patients: A retrospective cohort study in aFangcang shelter hospital. PLoS One. 2020;15(10):e0240959.
  19. Symptoms of coronavirus. US Centers for Disease Controland Prevention. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html%0APublished2020. Published 2020. Accessed April 27, 2020.
  20. Talavera B, García-Azorín D, Martínez-Pías E, et al.Anosmia is associated with lower in-hospital mortality inCOVID-19. J Neurol Sci. 2020;419:117163.
  21. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. ThePrevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis.Otolaryngol Neck Surg. 2020(1):3-11.
  22. Ji W, Zhang J, Bishnu G, et al. Comparison of severe andnon-severe COVID-19 pneumonia: review and meta-analysis.medRxiv. January 2020:2020.03.04.20030965.
  23. Zhou F, Yu T, Du R, et al. Clinical course and risk factorsfor mortality of adult inpatients with COVID-19 in Wuhan,China: a retrospective cohort study. Lancet.2020;395(10229):1054-1062.
  24. Yaribeygi H, Sathyapalan T, Jamialahmadi T, Sahebkar A.The Impact of Diabetes Mellitus in COVID-19: A MechanisticReview of Molecular Interactions. Chiefari E, ed. J DiabetesRes. 2020;2020:5436832.
  25. Menezes Soares R de C, Mattos LR, Raposo LM. Risk Factorsfor Hospitalization and Mortality due to COVID-19 in EspíritoSanto State, Brazil. Am J Trop Med Hyg. 2020;103(3):1184-1190.
  26. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cellRNA expression profiling of ACE2, the putative receptor ofWuhan 2019-nCov. bioRxiv. January2020:2020.01.26.919985.
  27. Li K, Wu J, Wu F, et al. The Clinical and Chest CT FeaturesAssociated With Severe and Critical COVID-19 Pneumonia.Invest Radiol. 2020;55(6):327-331

This document is currently not available here.

Share

COinS